Abstract

    Open Access Case Report Article ID: GJMCCR-2-121

    Hepatotoxicity after Sevoflurane Exposure in a Patient with Chronic Hepatitis C

    Nickul N Shah*, Nina Ballone, Raul Zamora, Peter DeVito, Samuel Wilson

    Sevoflurane is considered a safe inhaled anesthetic of choice in patients with liver disease. Compared to other halogenated inhaled anesthetics, Sevoflurane is reported to lessen the severity of decreased hepatic blood flow and undergoes a different mechanism of hepatic metabolism. In patients with preexisting liver disease, there is potential for low-flow Sevoflurane to induce acute liver damage through other mechanisms. Limited data exists to guide clinical decision-making when quantifying the severity of cirrhosis in patients with hepatitis C and its relationship to anesthesia choice. Previous studies have found that exposure to general anesthesia during abdominal surgery may increase the risk of hepatorenal failure. This study has raised a concern that anesthetics may interfere with various hepatic functions secondary to viral infection. The generation of abnormal liver enzymes and hypercoagulation has provided further exploration for such toxicity.

    Keywords: Chronic Hepatitis C; Cirrhosis; Sevoflurane; Disseminated Intravascular Coagulation; Elective Hernia Repair

    Published on: Dec 17, 2015 Pages: 23-27

    Full Text PDF Full Text HTML DOI: 10.17352/2455-5282.000021
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJMCCR